Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases

REFERENCES

• Mayor S, Riezman H. Sorting GPI-anchored proteins. Nat Rev Mol Cell Biol 2004; 5(2):110-20; PMID:15040444; http://dx.doi.org/10.1038/nrm1309
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77; PMID:18558863; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289(5486):1925-8; PMID:10988071; http://dx.doi.org/10.1126/science.289.5486.1925
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93(3):337-48; PMID:9590169; http://dx.doi.org/10.1016/S0092-8674(00)81163-0
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004; 116(2):313-27; PMID:14744440; http://dx.doi.org/10.1016/S0092-8674(03)01031-6
   PubMed Web of Science ®Google Scholar
• Geissen M, Krasemann S, Matschke J, Glatzel M. Understanding the natural variability of prion diseases. Vaccine 2007; 25(30):5631-6; PMID:17391814; http://dx.doi.org/10.1016/j.vaccine.2007.02.041
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, et al. Genetic prion disease: the EUROCJD experience. Hum Genet 2005; 118(2):166-74; PMID:16187142; http://dx.doi.org/10.1007/s00439-005-0020-1
   PubMed Web of Science ®Google Scholar
• Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, et al., Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med 2016; 8(322):322ra9; PMID:26791950
   PubMed Web of Science ®Google Scholar
• Puig B, Altmeppen H, Glatzel M. The GPI-anchoring of PrP: Implications in sorting and pathogenesis. Prion 2014; 8(1):11-8; PMID:24509692; http://dx.doi.org/10.4161/pri.27892
   PubMed Web of Science ®Google Scholar
• Zurzolo C, Simons K. Glycosylphosphatidylinositol-anchored proteins: Membrane organization and transport. Biochim Biophys Acta 2016; 1858(4):632-9; PMID:26706096; http://dx.doi.org/10.1016/j.bbamem.2015.12.018
   PubMed Web of Science ®Google Scholar
• Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. Embo J 2001 20(19):5383-91; PMID:11574470; http://dx.doi.org/10.1093/emboj/20.19.5383
   PubMed Web of Science ®Google Scholar
• Anelli T, Sitia R. Protein quality control in the early secretory pathway. EMBO J 2008; 27(2):315-27; PMID:18216874; http://dx.doi.org/10.1038/sj.emboj.7601974
   PubMed Web of Science ®Google Scholar
• Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol 2005; 7(8):766-72; PMID:16056268; http://dx.doi.org/10.1038/ncb0805-766
   PubMed Web of Science ®Google Scholar
• Satpute-Krishnan P, Ajinkya M, Bhat S, Itakura E, Hegde RS, Lippincott-Schwartz J. ER stress-induced clearance of misfolded GPI-anchored proteins via the secretory pathway. Cell 2014; 158(3):522-33; PMID:25083867; http://dx.doi.org/10.1016/j.cell.2014.06.026
   PubMed Web of Science ®Google Scholar
• Puig B, Altmeppen HC, Ulbrich S, Linsenmeier L, Krasemann S, Chakroun K, Acevedo-Morantes CY, Wille H, Tatzelt J, Glatzel M. Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice. Sci Rep 2016; 6:24970; PMID:27117504; http://dx.doi.org/10.1038/srep24970
   PubMed Web of Science ®Google Scholar
• Schipanski A, Lange S, Segref A, Gutschmidt A, Lomas DA, Miranda E, Schweizer M, Hoppe T, Glatzel M. A novel interaction between ageing and ER overload in a protein conformational dementia. Genetics 2013; 193(3):865-76; PMID:23335331; http://dx.doi.org/10.1534/genetics.112.149088
   PubMed Web of Science ®Google Scholar
• Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334(6059):1081-6; PMID:22116877; http://dx.doi.org/10.1126/science.1209038
   PubMed Web of Science ®Google Scholar
• Hetz C, Mollereau B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014; 15(4):233-49; PMID:24619348; http://dx.doi.org/10.1038/nrn3689
   PubMed Web of Science ®Google Scholar
• Hetz CA, Soto C. Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med 2006; 6(1):37-43; PMID:16472111; http://dx.doi.org/10.2174/156652406775574578
   PubMed Web of Science ®Google Scholar
• Ashok A, Hegde RS. Retrotranslocation of prion proteins from the endoplasmic reticulum by preventing GPI signal transamidation. Mol Biol Cell 2008; 19(8):3463-76; PMID:18508914; http://dx.doi.org/10.1091/mbc.E08-01-0087
   PubMed Web of Science ®Google Scholar
• Jin T, Gu Y, Zanusso G, Sy M, Kumar A, Cohen M, Gambetti P, Singh N. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem 2000; 275(49):38699-704; PMID:10970892; http://dx.doi.org/10.1074/jbc.M005543200
   PubMed Web of Science ®Google Scholar
• Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci U S A 2001; 98(26):14955-60; http://dx.doi.org/10.1073/pnas.011578098
   PubMed Web of Science ®Google Scholar
• Lloyd SE, Maytham EG, Pota H, Grizenkova J, Molou E, Uphill J, Hummerich H, Whitfield J, Alpers MP, Mead S, Collinge J. HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 2009; 5(2):e1000383; http://dx.doi.org/10.1371/journal.pgen.1000383
   Google Scholar
• Hetz C, Russelakis-Carneiro M, Wälchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005; 25(11):2793-802; PMID:15772339; http://dx.doi.org/10.1523/JNEUROSCI.4090-04.2005
   PubMed Web of Science ®Google Scholar
• Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J, Dinsdale D, Ortori CA, et al. Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 2012; 485(7399):507-11; PMID:22622579
   PubMed Web of Science ®Google Scholar
• Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 2013; 5(206):206ra138; PMID:24107777
   PubMed Web of Science ®Google Scholar
• Unterberger U, Höftberger R, Gelpi E, Flicker H, Budka H, Voigtländer T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol 2006; 65(4):348-57; PMID:16691116
   PubMed Web of Science ®Google Scholar
• Quaglio E, Restelli E, Garofoli A, Dossena S, De Luigi A, Tagliavacca L, Imperiale D, Migheli A, Salmona M, Sitia R, et al. Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction. PLoS One 2011; 6(4):e19339; PMID:21559407
   PubMed Web of Science ®Google Scholar
• Peters SL, Dery MA, LeBlanc AC. Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP. Hum Mol Genet 2016; 25(5):976-88; PMID:26740554
   PubMed Web of Science ®Google Scholar
• Torres M, Matamala JM, Duran-Aniotz C, Cornejo VH, Foley A, Hetz C. ER stress signaling and neurodegeneration: At the intersection between Alzheimer disease and Prion-related disorders. Virus Res 2015; 207:69-75; PMID:25556124
   PubMed Web of Science ®Google Scholar
• Kang S, Kim MH, Park IA, Kim JW, Park NH, Kang D, Yoo KY, Kang SB, Lee HP, Song YS. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix. Cancer Lett 2006; 237(2):305-11; PMID:16111807
   PubMed Web of Science ®Google Scholar
• Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, Fioriti L, Chiesa R, Harris DA. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 2003; 278(24):21732-43; PMID:12663673
   PubMed Web of Science ®Google Scholar
• Ashok A, Hegde RS. Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 2009; 5(6):e1000479; PMID:19543376
   PubMed Web of Science ®Google Scholar
• Sikorska, N, Lemus L, Aguilera-Romero A, Manzano-Lopez J, Riezman H, Muñiz M, Goder V. Limited ER quality control for GPI-anchored proteins. J Cell Biol 2016; 213(6):693-704; PMID:27325793
   PubMed Web of Science ®Google Scholar
• Chiesa, R, Piccardo P, Ghetti B, Harris DA. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 1998; 21(6):1339-51; PMID:9883727
   PubMed Web of Science ®Google Scholar
• Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B, Harris DA. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A, 2000; 97(10):5574-9
   PubMed Web of Science ®Google Scholar
• Ivanova L, Barmada S, Kummer T, Harris DA. Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 2001; 276(45):42409-21; PMID:11527974
   PubMed Web of Science ®Google Scholar
• Biasini E, Medrano AZ, Thellung S, Chiesa R, Harris DA. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion. J Neurochem 2008; 104(5):1293-308; PMID:18034781
   PubMed Web of Science ®Google Scholar
• Bouybayoune I, Mantovani S, Del Gallo F, Bertani I, Restelli E, Comerio L, Tapella L, Baracchi F, Fernández-Borges N, Mangieri M, et al. Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease. PLoS Pathog 2015; 11(4):e1004796
   PubMed Web of Science ®Google Scholar
• Senatore A, Restelli E, Chiesa R. Synaptic dysfunction in prion diseases: a trafficking problem? Int J Cell Biol 2013; 2013:543803; PMID:24369467
   PubMedGoogle Scholar
• Chiesa R, Restelli E, Comerio L, Del Gallo F, Imeri L. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity. Prion 2016; 10(2):93-102
   PubMed Web of Science ®Google Scholar
• Senatore A, Colleoni S, Verderio C, Restelli E, Morini R, Condliffe SB, Bertani I, Mantovani S, Canovi M, Micotti E, et al. Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)delta-1 Subunit. Neuron 2012; 74(2):300-13; PMID:22542184
   PubMed Web of Science ®Google Scholar
• Wilson C, Venditti R, Rega LR, Colanzi A, D'Angelo G, De Matteis MA. The Golgi apparatus: an organelle with multiple complex functions. Biochem J 2011; 433(1):1-9
   PubMed Web of Science ®Google Scholar
• Li Y, Kane T, Tipper C, Spatrick P, Jenness DD. Yeast mutants affecting possible quality control of plasma membrane proteins. Mol Cell Biol 1999; 19(5):3588-99; PMID:10207082
   PubMed Web of Science ®Google Scholar
• Arvan P, Zhao X, Ramos-Castaneda J, Chang A. Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 2002; 3(11):771-80; PMID:12383343
   PubMed Web of Science ®Google Scholar
• Castillon GA, Aguilera-Romero A, Manzano-Lopez J, Epstein S, Kajiwara K, Funato K, Watanabe R, Riezman H, Muñiz M. The yeast p24 complex regulates GPI-anchored protein transport and quality control by monitoring anchor remodeling. Mol Biol Cell 2011; 22(16):2924-36; PMID:21680708
   PubMed Web of Science ®Google Scholar
• Wang S, Ng DT. Evasion of endoplasmic reticulum surveillance makes Wsc1p an obligate substrate of Golgi quality control. Mol Biol Cell 2010; 21(7):1153-65; PMID:20130083
   PubMed Web of Science ®Google Scholar
• Tewari R, Bachert C, Linstedt AD. Induced oligomerization targets Golgi proteins for degradation in lysosomes. Mol Biol Cell 2015; 26(24):4427-37; PMID:26446839
   PubMed Web of Science ®Google Scholar
• Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J, Schätzl HM. Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. Embo J 2001; 20(15):3957-66; PMID:11483499
   PubMed Web of Science ®Google Scholar
• Nunziante M, Kehler C, Maas E, Kassack MU, Groschup M, Schätzl HM. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication. Journal of Cell Science 2005; 118: http://dx.doi.org/10.1242/jcs.02609
   PubMed Web of Science ®Google Scholar
• Darling NJ, Cook SJ. The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim Biophys Acta 2014; 1843(10):2150-63; PMID:24440275
   PubMed Web of Science ®Google Scholar
• Cancino J, Capalbo A, Di Campli A, Giannotta M, Rizzo R, Jung JE, Di Martino R, Persico M, Heinklein P, Sallese M, et al. Control systems of membrane transport at the interface between the endoplasmic reticulum and the Golgi. Dev Cell 2014; 30(3):280-94; PMID:25117681
   PubMed Web of Science ®Google Scholar
• Giannotta M, Ruggiero C, Grossi M, Cancino J, Capitani M, Pulvirenti T, Consoli GM, Geraci C, Fanelli F, Luini A, et al. The KDEL receptor couples to Galphaq/11 to activate Src kinases and regulate transport through the Golgi. Embo J 2012; 31(13):2869-81; PMID:22580821
   PubMed Web of Science ®Google Scholar
• Pulvirenti T, Giannotta M, Capestrano M, Capitani M, Pisanu A, Polishchuk RS, San Pietro E, Beznoussenko GV, Mironov AA, Turacchio G, et al. A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway. Nat Cell Biol 2008; 10(8):912-22; PMID:18641641
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Fujii R, Toyofuku Y, Saito T, Koseki H, Hsu VW, Aoe T. The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum. Embo J 2001; 20(12):3082-91; PMID:11406585
   PubMed Web of Science ®Google Scholar
• Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15(1):11-8; PMID:15686620
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Hamada H, Shinkai H, Kohno Y, Koseki H, Aoe T. The KDEL receptor modulates the endoplasmic reticulum stress response through mitogen-activated protein kinase signaling cascades. J Biol Chem 2003; 278(36):34525-32; PMID:12821650
   PubMed Web of Science ®Google Scholar
• Murakami Y, Aizu-Yokota E, Sonoda Y, Ohta S, Kasahara T. Suppression of endoplasmic reticulum stress-induced caspase activation and cell death by the overexpression of Bcl-xL or Bcl-2. J Biochem 2007; 141(3):401-10; PMID:17301078
   PubMed Web of Science ®Google Scholar
• Barmada SJ, Harris DA. Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. J Neurosci 2005; 25(24):5824-32; PMID:15958749
   PubMed Web of Science ®Google Scholar
• Stewart RS, Piccardo P, Ghetti B, Harris DA. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 2005; 25(13):3469-77; PMID:15800202
   PubMed Web of Science ®Google Scholar
• Uchiyama K, Muramatsu N, Yano M, Usui T, Miyata H, Sakaguchi S. Prions disturb post-Golgi trafficking of membrane proteins. Nat Commun, 2013; 4:1846
   PubMed Web of Science ®Google Scholar
• Massignan T, Biasini E, Lauranzano E, Veglianese P, Pignataro M, Fioriti L, Harris DA, Salmona M, Chiesa R, Bonetto V. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor α (GDI)/Rab11 pathway. Mol Cell Proteomics 2010; 9(4):611-22; PMID:19996123
   PubMed Web of Science ®Google Scholar
• Puig B, Ferrer I. Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease. Acta Neuropathol 2001; 102(3):207-15; PMID:11585244
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Ferrer I. Expression of transcription factors CREB and c-Fos in the brains of terminal Creutzfeldt-Jakob disease cases. Neurosci Lett 2007; 421(1):10-5; PMID:17548164
   PubMed Web of Science ®Google Scholar
• Zafar S, Schmitz M, Younus N, Tahir W, Shafiq M, Llorens F, Ferrer I, Andéoletti O, Zerr I. Creutzfeldt-Jakob disease subtype-specific regional and temporal regulation of ADP Ribosylation Factor-1-dependent Rho/MLC pathway at pre-clinical stage. J Mol Neurosci 2015; 56(2):329-48; PMID:25896910
   PubMed Web of Science ®Google Scholar